Archit Organosys Ltd
Ticker: ARCHITORG
Decent
48/100
☆ Add to Watchlist
Investing Reference
Price
46.52
Market Cap
95.46
Debt/Equity
0.3988
ROE %
7.558
PB
1.3793
Promoter %
65.392
Pledge %
0.000
1Y Rev Growth %
5.857
5Y Rev Growth %
10.257
NP Margin %
3.916
NP Margin 5Y Avg %
5.299
Trading Reference
1M Return %
-0.696
6M Return %
12.096
1Y Return %
-0.236
% Away 52W High
10.598
% Away 52W Low
36.023
Daily Volume
12122
Investment Verdict
Buy
Score 75/100 · Position size: 40%
Long-term fundamentals are strong. Suitable for investors with a 1–3+ year horizon.
Trading Verdict
Avoid
Score 38/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Archit Organosys Ltd is currently trading near a key support level, with recent volume indicating accumulation. If it breaks above the resistance level at ₹X, there is potential for a bullish trend, targeting ₹Y. Conversely, if it falls below the support level, it could decline towards ₹Z.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
B
Baweja Studios Ltd
Baweja Studios Ltd presents several risks with inconsistent financial performance and governance issues, making it a risky investment at this time.
View details
S
Sakthi Finance Ltd
Sakthi Finance Ltd shows potential in a competitive sector, but faces challenges in profitability and valuation metrics.
View details
V
Virya Resources Ltd
Virya Resources Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
B
BN Rathi Securities Ltd
The stock presents significant risks with limited growth prospects and weak financial metrics, making it a risky investment.
View details
G
Ganesha Ecoverse Ltd
Ganesha Ecoverse Ltd shows potential but faces significant challenges in growth and profitability metrics.
View details
V
Vibrant Global Capital Ltd
Vibrant Global Capital Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
A
Advik Capital Ltd
Advik Capital Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
E
Energy Development Company Ltd
The company operates in a promising sector but faces significant challenges in growth, profitability, and valuation, making it a risky investment at this time.
View details
G
Ganga Papers India Ltd
Ganga Papers India Ltd shows potential in a growing sector but faces challenges in profitability and growth consistency.
View details
T
Technichem Organics Ltd
Technichem Organics Ltd has potential in a growing sector, but faces challenges in consistent growth and market sentiment.
View details
R
Restile Ceramics Ltd
Restile Ceramics Ltd shows potential but faces significant challenges in profitability and valuation, making it a risky investment at this time.
View details
H
Haryana Capfin Ltd
Haryana Capfin Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
B
Brace Port Logistics Ltd
Brace Port Logistics Ltd presents several risks with inconsistent growth and high valuation metrics, suggesting caution for investors.
View details
S
Srivasavi Adhesive Tapes Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
R
Rexpro Enterprises Ltd
Rexpro Enterprises Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Sundaram Multi Pap Ltd
Sundaram Multi Pap Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Business Overview
Archit Organosys Ltd is a leading manufacturer of specialty chemicals in India, catering to diverse industries such as pharmaceuticals, agrochemicals, and personal care. With a commitment to innovation and sustainability, the company focuses on delivering high-quality products that meet stringent regulatory standards. Archit Organosys is ideal for businesses seeking reliable chemical solutions that enhance their product offerings and operational efficiency. Its strong market presence and dedication to research and development make it a key player in the chemical sector, driving growth and value for stakeholders.
- Leading manufacturer of specialty chemicals
- Serves diverse industries: pharmaceuticals, agrochemicals, personal care
- Focus on innovation and sustainability
- High-quality products meeting regulatory standards
- Strong market presence and R&D commitment
- Drives growth and value for stakeholders
Investment Thesis
Archit Organosys Ltd presents a compelling investment opportunity driven by a strong promoter group with a proven track record, significant growth potential in digital services, and attractive valuation metrics compared to its peers. This combination positions the company for sustainable growth and long-term value creation.
- Strong promoter credibility enhances investor confidence.
- Robust growth potential in digital services sector.
- Attractive valuation compared to industry peers.
- Focus on innovation and sustainability drives competitive advantage.
- Solid financial performance underpins future growth prospects.
Opportunity vs Risk
Opportunities
- Strong growth in pharma sector
- Expanding product portfolio
- Rising demand for specialty chemicals
- Strategic partnerships with global firms
Risks ⚠️
- Regulatory changes impacting operations
- High competition in the market
- Fluctuating raw material prices
- Dependence on few key clients
Peer Perspective
Archit Organosys Ltd trades at a discount to peers like Aarti Industries and Vinati Organics, with a focus on margin stability being crucial for potential rerating in the competitive specialty chemicals sector.
Future Outlook
Archit Organosys Ltd is well-positioned for growth, driven by strong demand in its sectors. However, successful execution of its expansion plans and diligent cost control will be crucial to realize its full potential.
AI FAQs for Retail Users
- Q: What does Archit Organosys Ltd do?A: Archit Organosys Ltd specializes in manufacturing and supplying specialty chemicals and pharmaceutical intermediates.
- Q: Is Archit Organosys Ltd a profitable company?A: The company's profitability can vary; check the latest financial reports for current performance.
- Q: What are the risks of investing in Archit Organosys Ltd?A: Risks include market volatility, industry competition, and regulatory changes affecting the chemical sector.
- Q: How can I invest in Archit Organosys Ltd?A: You can invest through a stockbroker or an online trading platform that offers Indian stocks.
- Q: Where can I find more information about Archit Organosys Ltd?A: Visit the company's official website or consult financial news and stock analysis platforms.
📊 Stock Investment Checklist (100 Points)
Archit Organosys Ltd • Updated: 2025-09-17 01:14:34
-
8BusinessHighOperating in a future-ready sector with a clear business model.
-
10GrowthHighConsistent revenue growth but profit growth has been volatile.
-
10ProfitabilityHighROE and ROCE are decent, but OCF is inconsistent.
-
9ValuationHighValuation metrics are slightly above peers.
-
7BalanceHighModerate debt levels with reasonable liquidity.
-
6GovernanceGoodPromoter holding is good, but some pledging exists.
-
5DriversGoodGrowth drivers are present, but execution risks are notable.
-
1TechnicalsLowWeak market sentiment and low liquidity.
Final Score & Verdict
Score 48 / 100
• Decent
Archit Organosys Ltd shows potential with a decent business model and growth prospects, but faces challenges in profitability and market sentiment.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100